Novartis AG

Common Name
Novartis
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103,000
Ticker
NOVN
Exchange
SIX SWISS EXCHANGE
Description
Novartis AG is a global healthcare company that operates in the pharmaceuticals and biotechnology sectors. Its primary function is to research, develop, and manufacture healthcare products, with a foc...

Novartis's GHG Emissions Data Preview

In 2024, Novartis completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Novartis has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Novartis's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Novartis’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novartis’s data sources below and access millions more through our Disclosure Search.

a. Novartis's ESG Data Spreadsheet 2024
Trace every data point back to Novartis’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. Novartis's Sustainability Data Spreadsheet 2019
Trace every data point back to Novartis’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

c. Novartis's ESG Data Spreadsheet 2021
Trace every data point back to Novartis’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Novartis's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Novartis amounted to 407,400 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Novartis decreased by 8.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Novartis's Scope 1 Emissions Over Time

20182019202020212022202320240150 k300 k450 k600 ktCO2e+1%-22%-27%-5%-5%-18%
  • Total Scope 1
  • Year-over-Year Change

What are Novartis's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Novartis were 207,000 metric tons of CO₂ equivalent (tCO₂e). a

Has Novartis reduced its Scope 1 emissions over time?

Since 2018, Novartis's Scope 1 emissions have decreased by 56.88%, reflecting a declining long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), Novartis's Scope 1 emissions decreased by 17.56%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Novartis's Scope 2 emissions?

In 2024, Novartis reported Scope 2 greenhouse gas (GHG) emissions of 30,000 tCO₂e using the market-based method and 200,400 tCO₂e using the location-based method. a

Has Novartis reduced its Scope 2 emissions over time?

Since 2018, Novartis's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 62.19%, reflecting a declining long-term trend in Scope 2 emissions over time. a c

Compared to the previous year (2023), Novartis's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Novartis 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Novartis use for Scope 2 reporting?

In 2024, Novartis reported its Scope 2 emissions using the market-based method and using the location-based method. a

Novartis's Scope 2 Emissions Over Time

20182019202020212022202320240150 k300 k450 k600 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Novartis's Value Chain Emissions

In 2024, Novartis reported 4,350,300 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Novartis includes a breakdown across 12 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Novartis's Scope 3 Emissions Over Time

201820192020202120222023202402 M4 M6 M8 MtCO2e+9%+20%-36%+7%-8%-5%
  • Total Scope 3
  • Year-over-Year Change

What are Novartis's Scope 3 emissions?

In 2024, Novartis reported total Scope 3 emissions of 4,350,300 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 95.77% of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.23% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Novartis reduced its Scope 3 emissions over time?

Since 2018, Novartis's Scope 3 emissions have decreased by 21.46%, reflecting a declining long-term trend in Scope 3 emissions over time. a b

Compared to the previous year (2023), Novartis's Scope 3 emissions remained relatively stable, indicating that Novartis 's emissions have plateaued with no significant change in its value chain footprint. a

What categories of Scope 3 emissions does Novartis disclose?

In 2024, Novartis reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Novartis's Scope 3 emissions?

In 2024, the largest contributors to Novartis's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 3,372,500 tCO₂e (77.52%)
  • Capital Goods (Cat. 2): 195,700 tCO₂e (4.5%)
  • Upstream Transportation and Distribution (Cat. 4): 166,000 tCO₂e (3.82%)

Novartis's Scope 3 Emissions by Categories

UpstreamTransportation andDistribution(Cat. 4)(3.8%)Capital Goods(Cat. 2)(4.5%)Purchased Goods andServices (Cat. 1)(77.5%)

Insights into Novartis's Total Carbon Footprint

In 2024, Novartis reported a total carbon footprint of 4,757,700 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.22% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a

The largest contributor to Novartis's total carbon footprint was Scope 3 emissions, accounting for 91.44% of the company's total carbon footprint, followed by Scope 1 emissions at 4.35%. a

Want Full Access to Novartis's GHG Emissions Dataset?
Sign Up